The awards recognise and reward innovation and excellence and are universally regarded as the ‘Oscars’ of the Plastics industry – and BioCote (together with development partner Matrix Plastics) were recognised for antimicrobial masterbatches that set standards globally and continue to optimise stringent quality levels within the medical, pharmaceutical and healthcare sectors.
BioCote has enjoyed a highly successful 12-year partnership with compounder Matrix Plastics, which provides unlimited laboratory and production capacity to consistently develop many pioneering combinations of additive formulation.
Both technical service departments work closely together to produce, monitor and test products to ensure they meet the highest specification available to market – and together they offer an unrivalled knowledge and expertise of microbiology and materials chemistry.
BioCote antimicrobial additives make all kinds of surfaces inhospitable to harmful microbes, including Campylobacter, Listeria, E.coli, Salmonella, viruses like H1N1 influenza and even antibiotic resistant bacteria strains such as MRSA and Candida auris.
Exposure to BioCote treated plastics and polymers reduces their presence by up to 99.99% through protein damage, membrane disruption and DNA interference.
